Use of Spinal Cord Stimulators in Patients With Pacemakers or Implantable Cardiac Defibrillators: A Review of Documented Accounts of Interference

ConclusionsInterference between cardiac devices and SCSs is a rare occurrence. As there are currently no published guidelines, devices should be interrogated on a case-by-case basis in the SCS trial period (if implanted after cardiac device), during permanent implantation, and during scheduled follow-up visits. Peri-operative testing should include increasing the SCS settings to maximally tolerated levels with cardiac device set at its maximum sensitivity.

Source: Neuromodulation: Technology at the Neural Interface - July 30, 2021 Category: Biotechnology Authors: Joshua Manuel Martens, Kenneth Fiala, Christopher Glover, Nicholas Zacharias, Alaa Abd ‐Elsayed Tags: Review Article Source Type: research